Lassa Fever Archives - Page 2 of 3

Press release

Zalgen Labs awarded NIH grant to advance diagnostic products

VHFC partner, Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected…

Kristian AndersenMarch 26, 2018

Publication

VHFC researchers describe predictors of Lassa fever outcome

A team of scientists at led by Pardis Sabeti at the Broad Institute has published…

Kristian AndersenMarch 12, 2018

Press release

Partner center CViSB launched with a $15 million grant from NIAID

With a new $15 million grant, VHFC scientists at Scripps Research are gearing up for…

Kristian AndersenFebruary 27, 2018

Press release

Tulane University awarded $12 million to create Lassa vaccine and treatment

The National Institutes of Health has awarded Tulane University more than $12 million to test…

adminJuly 12, 2017

Publication

VHFC researchers solve the structure of Lassa virus glycoprotein

A team of scientists at Scripps Research (Scripps Research) in La Jolla, California has published…

adminJune 5, 2017

Press release

Zalgen Labs Launches E-Commerce Platform for Hemorrhagic Fever Products

Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases,…

adminDecember 13, 2016

Publication

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Abstract - Lassa fever is a significant health threat to West African human populations with…

adminOctober 1, 2016

Press release

Zalgen Labs Introduces Viral Diagnostics Business

Opens Advanced Product Development Center in Colorado GERMANTOWN, MD AND DENVER – August 22, 2016…

adminAugust 22, 2016

Publication

New Lassa fever study published in Nature Communications

Lassa fever is a severe multisystem disease that often has haemorrhagic manifestations. The epitopes of…

Kristian AndersenMay 18, 2016

Publication

VHFC researchers publish key findings on Lassa virus

In a large multi-disciplinary collaboration, researchers from the Viral Hemorrhagic Fever Consortium (VHFC) have published…

Kristian AndersenAugust 13, 2015

Lassa Fever

Zalgen Labs awarded NIH grant to advance diagnostic products

VHFC researchers describe predictors of Lassa fever outcome

Partner center CViSB launched with a $15 million grant from NIAID

Tulane University awarded $12 million to create Lassa vaccine and treatment

VHFC researchers solve the structure of Lassa virus glycoprotein

Zalgen Labs Launches E-Commerce Platform for Hemorrhagic Fever Products

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Zalgen Labs Introduces Viral Diagnostics Business

New Lassa fever study published in Nature Communications

VHFC researchers publish key findings on Lassa virus

Recent

Popular

About

Consortium

Latest News

Lassa Fever

Recent

Popular

Tags

About

Consortium

Latest News